TickerFactsScreenerDevelopers

Travere Therapeutics, Inc. (TVTX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2012: $24.8K2013: $117.0K2014: $663.0K2015: $22.0K2016: $1.43M2017: $887.0K2018: $727.0K2019: $195.0K2020: $6.77M2021: $5.10M2022: $191.0K2023: $668.0K$668.0K
2012Capital Expenditures (USD)2023
Fiscal YearCapital ExpendituresChange YoY
2023$668.0K+249.7%
2022$191.0K-96.3%
2021$5.10M-24.6%
2020$6.77M+3370.3%
2019$195.0K-73.2%
2018$727.0K-18.0%
2017$887.0K-37.9%
2016$1.43M+6390.9%
2015$22.0K-96.7%
2014$663.0K+466.7%
2013$117.0K+372.3%
2012$24.8K—